Ibrahim A Taher (Ibrahim Taher)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Angiotensin Converting Enzyme

Endoplasmic Reticulum

Top Venues

Diagnostics (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Abu-Farha, Dhanya Madhu, Prashantha Hebbar, Anwar Mohammad, Arshad Channanath, Sina Kavalakatt, Nada Alam-Eldin, Fatima Alterki, Ibrahim A Taher, Osama Alsmadi, Mohammad Shehab, Hossein Arefanian, Rasheed Ahmad, Thangavel Alphonse Thanaraj, Fahd Al-Mulla, Jehad Abubaker
The Proinflammatory Role of ANGPTL8 R59W Variant in Modulating Inflammation through NF-κB Signaling Pathway under TNFα Stimulation. Cells 12 (21) (2023)
Amany A Ghazy, Abdulrahman H Almaeen, Ibrahim A Taher, Abdullah N Al-Rasheedi, Amel Elsheredy
Impact of ACE and Endoplasmic Reticulum Aminopeptidases Polymorphisms on COVID-19 Outcome. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Amany A Ghazy, Abdulrahman H Almaeen, Ibrahim A Taher, Abdullah N Al-Rasheedi, Amel Elsheredy
Impact of ACE and Endoplasmic Reticulum Aminopeptidases Polymorphisms on COVID-19 Outcome. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Amany A Ghazy, Abdulrahman H Almaeen, Ibrahim A Taher, Abdullah N Al-Rasheedi, Amel Elsheredy
Impact of ACE and Endoplasmic Reticulum Aminopeptidases Polymorphisms on COVID-19 Outcome. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Mohamed Abu-Farha, Shibu Joseph, Anwar Mohammad, Arshad Channanath, Ibrahim A Taher, Fahd Al-Mulla, Muhammad Mujammami, Thangavel Alphonse Thanaraj, Jehad Abubaker, Anas M Abdel Rahman
Targeted Metabolomics Analysis of Individuals Carrying the ANGPTL8 R59W Variant. Metabolites 13 (9) (2023)
Mohamed Abouelkheir, Ibrahim A Taher, Amira S R Eladl, Dalia A Shabaan, Mona F M Soliman, Ahmed E Taha
Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)